Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Símbolo: 2196.HK

HKSE

13.28

HKD

Precio de mercado actual

  • 15.5749

    Ratio PER

  • 7.2266

    Ratio PEG

  • 63.71B

    Capitalización MRK

  • 0.04%

    Rendimiento DIV

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Estructura directiva

Información sobre la dirección

NombreCargo
Ms. Xiaolei WuVice President & Chief Financial Officer
Mr. Wenjie ZhangExecutive President & Co-Chief Executive Officer of Innovative Drug Division
Ms. Jing LiExecutive President and Chief Executive Officer of Established Medicines Manufacturing & Supply Division
Mr. Wang Xingli M.D., Ph.D.Executive President, Co-Chief Executive Officer of Innovative Medicines Division and CEO of Global R&D Center
Mr. Shengli LiExecutive President & Chief Growth Officer
Ms. Rongli FengExecutive President, Chief Human Resources Officer & GM of Human Resources Department
Mr. Deyong WenJoint President,Chief Executive Officer & Executive Director
Mr. Kexin WangExecutive Co-Chairman
Mr. Yifang WuExecutive Chairman
Ms. Xiaohui GuanExecutive Vice Chairman